Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 22

Sort by

Sort Order Select

Journal Articles

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Jennifer Yui, MD, Scott A. Peslak, MD PhD, David Lambert, MD, Eric Russell, MD, Farzana Sayani, MD

Blood (2019) 134 (Supplement_1): 4678.

https://doi.org/10.1182/blood-2019-123868

Published: 2019

Journal Articles

Addressing Challenges in Chronic Lymphocytic Leukemia with Continuing Education: Impact on Practice Behaviors and Knowledge

Anne C Roc, PhD, Julie M. Vose, MD MBA, Susan M. O'Brien, MD, Wendy Turell, DrPH

Blood (2018) 132 (Supplement 1): 5851.

https://doi.org/10.1182/blood-2018-99-120174

Published: 2018

Journal Articles

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Blood (2018) 132 (20): 2115–2124.

https://doi.org/10.1182/blood-2018-07-862334

Published: 2018

Includes: Supplemental data

Journal Articles

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Blood (2017) 130 (Supplement 1): 5667.

https://doi.org/10.1182/blood.V130.Suppl_1.5667.5667

Published: 2017

Journal Articles

Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Sikander Ailawadhi, Maral DerSarkissian, PhD, Mei Sheng Duh, MPH, ScD, Marie-Hélène Lafeuille, MA, George Posner, BA, Stephen Ralston, PhD, Erin Zagadailov, PharmD, MS, Abbie Ba-Mancini, MSc, MBA, Robert M Rifkin, MD

Blood (2017) 130 (Supplement 1): 5599.

https://doi.org/10.1182/blood.V130.Suppl_1.5599.5599

Published: 2017

Journal Articles

Identifying Clinical Gaps in the Diagnosis, Monitoring, and Management of Immunoglobulin Light Chain (AL) Amyloidosis Among Hematologist/Oncologists

Emily S Van Laar, Morie A. Gertz, MD

Blood (2017) 130 (Supplement 1): 4672.

https://doi.org/10.1182/blood.V130.Suppl_1.4672.4672

Published: 2017

Journal Articles

Red Cell Exchange: A Concise Review of Indications and Management

Elizabeth Biller, Yong Zhao, Lejla Music-Aplenc, MD, Mary Berg, MD, Lisa N Boggio, MD MS, Theresa Boyd, Kelley Capocelli, Deanna C Fang, Scott A Koepsell, MD, PhD, FCAP, Huy P. Pham, MD, M.P.H., Angela Treml, John Weiss, Geoffrey D. Wool, MD PhD, Beverly W Baron

Blood (2017) 130 (Supplement 1): 4800.

https://doi.org/10.1182/blood.V130.Suppl_1.4800.4800

Published: 2017

Journal Articles

Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries

Christopher M Hillis, MD FRCPC, Lambert Busque, MD PhD FRCPC, Julie Stakiw, MD, Donna L. Forrest, MD FRCPC

Blood (2016) 128 (22): 3079.

https://doi.org/10.1182/blood.V128.22.3079.3079

Published: 2016

Journal Articles

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 2793.

https://doi.org/10.1182/blood.V128.22.2793.2793

Published: 2016

Journal Articles

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Blood (2016) 128 (22): 1622.

https://doi.org/10.1182/blood.V128.22.1622.1622

Published: 2016

Journal Articles

Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients

Blood (2015) 126 (23): 252.

https://doi.org/10.1182/blood.V126.23.252.252

Published: 2015

Journal Articles

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Anand Jillella, MD, Martha Arellano, MD, Asad Bashey, MD PhD, Sarah I. Vidito, DO, Robert K. Stuart, MD, Caleb Leung, Kaitlin Sitchenko, Manila Gaddh, MD, Leonard T Heffner, Jr., MD, Ravindra B. Kolhe, MD PhD, Jacques Galipeau, MD, Amelia Langston, MD, Vamsi K Kota, MD

Blood (2015) 126 (23): 3779.

https://doi.org/10.1182/blood.V126.23.3779.3779

Published: 2015

Journal Articles

Impact of Treatment Strategies on Clinical Outcomes In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients In Canada

Nancy Cribb, BSc, Tazmin Merali, BPharm, MBA, Bonnie MK Donato, PhD

Blood (2010) 116 (21): 2569.

https://doi.org/10.1182/blood.V116.21.2569.2569

Published: 2010

Journal Articles

Patterns of Management and Adherence to Venous Thromboembolism (VTE) Treatment Guidelines In a National Prospective Cohort Study of VTE Management In the Canadian Outpatient Setting: Recovery Study

Susan R Kahn, MD, MSc, Sam Schulman, Josée Martineau, John A Stewart, Anne McLeod, Carla Strulovitch, Mark Blostein, Jacques-Philippe Faucher, Greg Gamble, Wendy Gordon, Peter K. Kagoma, Marie-José Miron, David Laverdière, Melaku Game, Allan Mills

Blood (2010) 116 (21): 565.

https://doi.org/10.1182/blood.V116.21.565.565

Published: 2010

Journal Articles

Resource Utilization and Perceptions of Major Molecular Response In Chronic Myeloid Leukemia (CML): Results of a Delphi Panel Study.

Alfonso Quintas-Cardama, MD, Michael Flamm, MD, PhD, Michael Lill, M.D., Michael J Thirman, Farhad Ravandi, MD, Luke Paul Akard, MD, Moshe Talpaz, MD

Blood (2010) 116 (21): 4479.

https://doi.org/10.1182/blood.V116.21.4479.4479

Published: 2010

Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD

Blood (2008) 112 (11): 4393.

https://doi.org/10.1182/blood.V112.11.4393.4393

Published: 2008

Journal Articles

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?

Michael Burke, MD, Jennifer Willert, MD, Sunil J. Desai, MRCP, FRCPC, MB, CHB, Richard Kadota, MD

Blood (2008) 112 (11): 4399.

https://doi.org/10.1182/blood.V112.11.4399.4399

Published: 2008

Journal Articles

Radiologic and nuclear events: contingency planning for hematologists/oncologists

David M. Weinstock, Cullen Case, Jr, Judith L. Bader, Nelson J. Chao, C. Norman Coleman, Richard J. Hatchett, Daniel J. Weisdorf, Dennis L. Confer

Blood (2008) 111 (12): 5440–5445.

https://doi.org/10.1182/blood-2008-01-134817

Published: 2008

Includes: Supplemental data

Journal Articles

Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’ Oncology Group (COG) Study A2971.

Mukta Sharma, MD, Todd A. Alonzo, PhD, April Sorrell, MD, Robert B. Gerbing, MA, Joanne M. Hilden, MD, Robert J. Arceci, MD, PhD, Gita Massey, MD, John J. Doyle, MD, Lisa Bayer, CPNP, John P. Perentesis, MD, Julie Ross, PhD, Franklin O. Smith, MD, Russell Brynes, MD, Jerry Hussong, MD, Lois Hathaway, Alan Gamis, MD

Blood (2006) 108 (11): 376.

https://doi.org/10.1182/blood.V108.11.376.376

Published: 2006

Journal Articles

Uptake of New Therapeutics in the Treatment of Multiple Myeloma (MM) in Germany (GER) - Results from a Representative Multicentre Treatment Survey 2006.

Ralf Angermund, MD, W. Knauf, MD, M. Freund, MD, M. Nowrousian, MD, H. Einsele, MD, H. Goldschmidt, MD, W. Berdel, MD, W. Poenisch, MD, C. Straka, MD, L. Kellermann, H. Pliskat, PhD

Blood (2006) 108 (11): 5110.

https://doi.org/10.1182/blood.V108.11.5110.5110

Published: 2006

NARROW

Implementation of an Evidence-Based Care Pathway for Emergency Department Management of Sickle Cell Vaso-Occlusive Crisis Leads to Improved Clinical Outcomes

Addressing Challenges in Chronic Lymphocytic Leukemia with Continuing Education: Impact on Practice Behaviors and Knowledge

International, evidence-based consensus treatment guidelines for idiopathic multicentric Castleman disease

Improving Outcomes in Elderly Acute Promyelocytic Leukemia Patients in the Real World: A Personalized Treatment Approach Along with Expert Support Might Reduce Early Deaths

Cost Offsets in the Treatment Journeys of Patients with Relapsed/Refractory Multiple Myeloma (RRMM)

Identifying Clinical Gaps in the Diagnosis, Monitoring, and Management of Immunoglobulin Light Chain (AL) Amyloidosis Among Hematologist/Oncologists

Red Cell Exchange: A Concise Review of Indications and Management

Adherence to Chronic Myeloid Leukemia Monitoring and Treatment Guidelines in Canadian Registries

A Multi-Center Prospective Study Utilizing a Simplified Treatment Algorithm Complemented By Expert Support Decreases Induction Mortality and Improves Survival in Acute Promyelocytic Leukemia (APL). Results of the APL Trial in Georgia, South Carolina and Neighboring States

A Prospective Multi-Center Trial Shows Reduction of Early Deaths (ED) and Improved Survival in Elderly Acute Promyelocytic Leukemia (APL) Patients (>60 years). Results of Using a Simplified Treatment Algorithm and Expert Support in Georgia, South Carolina and Neighboring States

Acute Leukemias of Ambiguous Lineage; Study on 247 Pediatric Patients

Decreasing Early Deaths in Acute Promyelocytic Leukemia (APL) By Using a Simplified Treatment Algorithm and Establishing a Network with Academic and Community Centers in USA

Impact of Treatment Strategies on Clinical Outcomes In Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients In Canada

Patterns of Management and Adherence to Venous Thromboembolism (VTE) Treatment Guidelines In a National Prospective Cohort Study of VTE Management In the Canadian Outpatient Setting: Recovery Study

Resource Utilization and Perceptions of Major Molecular Response In Chronic Myeloid Leukemia (CML): Results of a Delphi Panel Study.

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Acute Lymphoblastic Leukemia (ALL): What Are They in today’s Imatinib Era?

Pediatric Treatment Guidelines for Philadelphia Positive (Ph+) Chronic Myelogenous Leukemia (CML): What Are They in Today’s Imatinib Era?

Radiologic and nuclear events: contingency planning for hematologists/oncologists

Uniform Approach Better Defines Natural History of Transient Myeloproliferative Disorder (TMD) in Down Syndrome (DS) Neonates: Outcomes from Children’ Oncology Group (COG) Study A2971.

Uptake of New Therapeutics in the Treatment of Multiple Myeloma (MM) in Germany (GER) - Results from a Representative Multicentre Treatment Survey 2006.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only